Screener
iRadimed IRMD Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue | 3,397 | 2,871 |
| Accrued income taxes | 3,902 | 1,814 |
| Total current liabilities | 12,118 | 10,180 |
| Deferred revenue, non-current | 3,757 | 3,978 |
| Total liabilities | $15,875 | 14,158 |
| Stockholders’ equity: | ||
| Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,782,837 shares issued and outstanding as of March 31, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025 | $1 | $1 |
| Additional paid-in capital | 31,020 | 30,386 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's contract liabilities, non-current?
- iRadimed (IRMD) reported contract liabilities, non-current of $3.76M in Q1 2026.
- How has iRadimed's contract liabilities, non-current changed year-over-year?
- iRadimed's contract liabilities, non-current increased by 17.3% year-over-year, from $3.2M to $3.76M.
- What is the long-term trend for iRadimed's contract liabilities, non-current?
- Over 5 years (2020 to 2025), iRadimed's contract liabilities, non-current has grown at a 11.5% compound annual growth rate (CAGR), from $2.31M to $3.98M.
Ask your AI about iRadimed's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude